Tags: Drug.
Fresolimumab (GC1008) is a human monoclonal antibody and an immunomodulator. It is intended for the treatment of idiopathic pulmonary fibrosis (IPF) focal segmental glomerulosclerosis and cancer (kidney cancer and melanoma).It binds to and inhibits all isoforms of the protein transforming growth factor beta (TGF-β).